Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Giralt

Showing results (1-10 of 340) with videos related to

Pageof 34
Sort By:
Blood|January 8, 2011
TMLI: a better TBI or more of the same?Sergio Giralt
Nature Reviews. Clinical Oncology|August 28, 2010
200 mg/m(2) melphalan--the gold standard for multiple myelomaSergio Giralt
Current Hematology Reports|April 17, 2004
Bone marrow transplant in myelodysplastic syndromes: new technologies, same questionsSergio Giralt
Hematology. American Society of Hematology. Education Program|November 24, 2005
Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?Sergio Giralt
Seminars in Oncology|May 25, 2006
The role of alemtuzumab in nonmyeloablative hematopoietic transplantationSergio Giralt
Journal of Oncology Practice|September 14, 2016
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Where Are We Going With This?Sergio Giralt
Blood|February 13, 2010
A TAD better for myeloma therapy?Sergio Giralt
Clinical Lymphoma & Myeloma|March 27, 2007
Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to dateSergio Giralt
Clinical Lymphoma & Myeloma|September 26, 2009
Advances in stem cell transplantation: making it better and saferSergio Giralt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Graft-versus-host disease: have we solved the problem?Sergio Giralt
Pageof 34

Showing results (1-10 of 340) with videos related to

Sort By:
Pageof 34
Blood|January 8, 2011
TMLI: a better TBI or more of the same?Sergio Giralt
Nature Reviews. Clinical Oncology|August 28, 2010
200 mg/m(2) melphalan--the gold standard for multiple myelomaSergio Giralt
Current Hematology Reports|April 17, 2004
Bone marrow transplant in myelodysplastic syndromes: new technologies, same questionsSergio Giralt
Hematology. American Society of Hematology. Education Program|November 24, 2005
Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?Sergio Giralt
Seminars in Oncology|May 25, 2006
The role of alemtuzumab in nonmyeloablative hematopoietic transplantationSergio Giralt
Journal of Oncology Practice|September 14, 2016
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Where Are We Going With This?Sergio Giralt
Blood|February 13, 2010
A TAD better for myeloma therapy?Sergio Giralt
Clinical Lymphoma & Myeloma|March 27, 2007
Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to dateSergio Giralt
Clinical Lymphoma & Myeloma|September 26, 2009
Advances in stem cell transplantation: making it better and saferSergio Giralt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Graft-versus-host disease: have we solved the problem?Sergio Giralt
Pageof 34